MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1

被引：39

作者：

Chang, Shuai ^{[1
]}

He, Shicai ^{[1
]}

Qiu, Guanglin ^{[1
]}

Lu, Jing ^{[1
]}

Wang, Jin ^{[1
]}

Liu, Junsong ^{[1
]}

Fan, Lin ^{[1
]}

Zhao, Wei ^{[1
]}

Che, Xiangming ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Dept Gen Surg, Affiliated Hosp 1, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China

来源：

TUMOR BIOLOGY | 2016年 / 37卷 / 09期

基金：

中国国家自然科学基金;

关键词：

Gastric cancer; Metastasis; MicroRNA-125b; NEU1; STARD13; TUMOR-SUPPRESSOR; FOCAL ADHESIONS; POOR-PROGNOSIS; EXPRESSION; MIR-125B; PROFILES; CELLS; PROLIFERATION; PROGRESSION; SIGNATURES;

D O I：

10.1007/s13277-016-5094-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MicroRNAs have been documented playing key roles in cancer development and progression. Here, we investigate the role of miR-125b in gastric cancer metastasis. We found that the expression of miR-125b was up-regulated in gastric cancer tissue specimens compared with their corresponding nontumorous tissues, and the up-regulated miR-125b level was significantly associated with TNM stage and lymph node-metastasis. Overexpression of miR-125b promoted gastric cancer cell migration and invasion in vitro and metastasis in vivo. STARD13 and NEU1 were identified as direct target genes of miR-125b by luciferase assays, and they were involved in the cell migration and invasion regulated by miR-125b in gastric cancer. Taken together, miR-125b functions as an oncogene in gastric cancer and represents a new potential therapeutic target for gastric cancer.

引用

页码：12141 / 12151

页数：11

共 54 条

[1] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
Bartel, David P.
[J]. CELL, 2007, 131 (04) : 11 - 29
[3] MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Bloomston, Mark
Frankel, Wendy L.
Petrocca, Fabio
Volinia, Stefano
Alder, Hansjuerg
Hagan, John P.
Liu, Chang-Gong
Bhatt, Darshna
Taccioli, Cristian
Croce, Carlo M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (17): : 1901 - 1908
[4] A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
Calin, GA
Ferracin, M
Cimmino, A
Di Leva, G
Shimizu, M
Wojcik, SE
Iorio, MV
Visone, R
Sever, NI
Fabbri, M
Iuliano, R
Palumbo, T
Pichiorri, F
Roldo, C
Garzon, R
Sevignani, C
Rassenti, L
Alder, H
Volinia, S
Liu, CG
Kipps, TJ
Negrini, M
Croce, CM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) : 1793 - 1801
[5] MicroRNA signatures in human cancers
Calin, George A.
Croce, Carlo M.
[J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
[6] Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma
Ching, YP
Wong, CM
Chan, SF
Leung, THY
Ng, DCH
Jin, DY
Ng, IOL
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) : 10824 - 10830
[7] Lymph Nodes and Gastric Cancer
Coburn, Natalie G.
[J]. JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (04) : 199 - 206
[8] Oncomirs - microRNAs with a role in cancer
Esquela-Kerscher, A
Slack, FJ
[J]. NATURE REVIEWS CANCER, 2006, 6 (04) : 259 - 269
[9] Timeline - The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
Fidler, IJ
[J]. NATURE REVIEWS CANCER, 2003, 3 (06) : 453 - 458
[10] MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
Garzon, Ramiro
Volinia, Stefano
Liu, Chang-Gong
Fernandez-Cymering, Cecilia
Palumbo, Tiziana
Pichiorri, Flavia
Fabbri, Muller
Coombes, Kevin
Alder, Hansjuerg
Nakamura, Tatsuya
Flomenberg, Neal
Marcucci, Guido
Calin, George A.
Kornblau, Steven M.
Kantarjian, Hagop
Bloomfield, Clara D.
Andreeff, Michael
Croce, Carlo M.
[J]. BLOOD, 2008, 111 (06) : 3183 - 3189

← 1 2 3 4 5 6 →